Charles Edward Hamner, Jr. DVM, PhD

**** ***** ****

Chapel Hill, N.C. 27516

919-***-****

EDUCATION:

PhD (Biochemistry) University of Georgia 1964

MA (Chemistry) University of Georgia 1962

DVM (Vet. Med.) University of Georgia 1960

BS (An. Sci.) Virginia Polytechnic Institute 1956

Honorary Degrees- For installing successful programs at various institutions

Hon. D. (science) University of Ulster, Northern Ireland

Hon. D. (letters) North Carolina State Univ.

Hon. D. (Public Service) Elizabeth City State Univ.

FIELDS OF SPECIALIZATION:

General management in pharmaceutical and health care industries to include senior line responsibilities, program planning and budget systems, facility construction and maintenance; academic administration at all levels, technology development, coordination of university/government/ industry interactions; research and teaching in biochemistry and molecular biology, was licensed to practice veterinary medicine and surgery in Virginia and Georgia.

PROFESSIONAL SOCIETIES:

American Association for the Advancement of Science

American Veterinary Medical Association

Biotechnology Industry Organization

Drug Information Association

FASEB, American Physiological Society

Society for the Study of Fertility

HONOR SOCIETIES AND AWARDS: For achievements in scholarship, research, and work related success in programs, product development, public service and public relations in the pharmaceutical and biotechnology industries.

Omicron Delta Kappa, Phi Kappa Phi, Phi Zeta, Alpha Zeta, Gamma Sigma Epsilon, Phi Sigma, Sigma Xi and Sigma Xi Award for Outstanding Research and PhD Thesis, 1964; Strathmore’s Who’s Who Registry of Business Leaders,1996/97;

Archie K. Davis Award for Development of RTP, 2001;

Charles Duncan McIver Medal, 2001; NC Order of the Long Leaf Pine, 2002; Healthcare Life Time Achievement Award, 2010;

NC award for Public Service, 2011; WRAL Tech-wire Lifetime Achievement Award in Biotechnology, WRAL Tech-wire Yardmaster; Nanotechnology lifetime Achievement Award, U. Of Georgia Distinguished Graduate Award, 2012; WRAL-Tech-wire NC Hall of Fame, 2017; RTP Rotary Club World Changers Award, 2018.

PROFESSIONAL EXPERIENCE:

ADMINISTRATION:

President and CEO, Hamner Consulting, 20 Hr./ Week; 2002 to present

Major consulting effort (15 years) spent with Franklin Street Partners wealth management; other consulting on case by case basis with various businesses in RTP (Obrien/ Atkins, Biogen, and start-up biotech companies: KBI, Spinner, K Sep Holdings, NCBIO, For past 2 years Senior Consult. to UNC-CH Sch. of Med./ Eschelman Sch. of Pharmacy on Rare Disease Study Initiative.

Average earnings: $25K/ yr.

Board of Directors, 2005- 2015, The Hamner Institutes for Health Sciences, Chairman, 2007- 2012; 15 hr./wk.; Honorary position.

The Institute was created by 5 major chemical companies. I helped increase this to 12 companies and created the pharmaceutical institute which grew to 18 major companies. THI was a leading chemical and drug safety testing organization with several of the world’s top toxicologist.

President and Chief Executive Officer, North Carolina Biotechnology Center, Research Triangle Park, NC, 2/1/88 – 3/31/02. Reported to the Chairman of the Board of Directors. Noted for working with UNC System in life sciences: By creating a Proof- of- Concept grant fund and a research discoveries and Eminent Scholars Program which brought to the universities 42 noted scientist and Noble Prize winners. In statewide economic development for creating a Loan Fund and Equity Investment Fund for start-up (now 100s) biotech companies. 40Hr./Wk.; Salary Ave. $110K.

Research Professor, OB/GYN Department, University of North Carolina at Chapel Hill, 7/1/88 – 6/30/02.

Associate Vice President for Health Affairs, University of Virginia Medical Center, 1979-1988. COO for 3 hospitals, 35 clinics and medical center (Medical Center Planning, development and day-to-day operations, combined budgets of $525 million and 6,000 employees). Project Director of the $206 million dollar Replacement Hospital and Related Facilities Project $425 M). Through serving on multifold university wide committees over a 20 year period helped raise UVa ranking to 3rd best public university. Made regular reports to the University Board of Visitors. 40 hr./wk; Salary ave. $100K.

(Interim Executive Director, University of Virginia hospitals, January 1981-July 1981). Managed combined budgets of $103 million in six (6) divisions and coordinated activities of 4,100 employees; ran day-to-day operations of a 700 bed Hospital and serving as Information Systems Executive for the development of a $20 million dollar Hospital Information System.

• Assistant Vice President for Health Services, University of Virginia Medical Center, 7/1/77-6/30/79. (Managed combined budgets of $82 million in four (4) divisions and coordinated activities of 2,900 employees.); 40 Hr./Wk.; salary

Ave. $75K.

Professor, Obstetrics and Gynecology, University of Virginia, 7/1/77-2/1/88.

• Director of Program Coordination in Research and Development, A.H. Robins Company, Richmond, Virginia, 1971-1978. (Coordinated R&D Budget of $14.3 million and activities of 284 scientists and technicians.) Developed five products (Reglan, Micro-K- Extencaps, Mitrolan, and Heparin for market with sales exceeding $500 million. Reformulated 10 Dimatapp and Robitussin, lipquincer formulations plus Biocox for poultry industry. Noted for project management of drug development process from idea to product sales. Stock price moved from $6 to $60 /share during these developments. Edited : Drug Development, CRC Press, 1980; 2nd edt, 1992.40Hr./Wk.; Salary Ave. $90K.

Associate Professor, Obstetrics and Gynecology, University of Virginia, 1967-1977.

• Director of Division of Reproductive Biology, University of Virginia School of Medicine, 1967-1977.

• Director of Vivarium and Assistant Professor, Surgery, University of Virginia Medical Center, 1964-1967. Oversaw construction of new vivarium (Budget $150,000/year, supervised 15 people.) $0 Hr./ Wk.; salary Ave. $ 25K.

. Veterinarian- USDA Poultry Inspection, July- Sept.,1960; 40Hr/Wk. $24K/yr.

REFERENCES

Mr. Douglas L. Edgeton, President and CEO, NC Biotechnology Center, P.O. Box 13547, Research Triangle Park, NC 27709 adjwqk@r.postjobfree.com 919- 314- 8347

INDUSTRY: BUSINESS AND PUBLIC SERVICE

Mr. William G. Hancock, Everett, Hancock and Gaskins. P.O. Box 911, Raleigh, NC 27602-0911. adjwqk@r.postjobfree.com ;, 919-***-****.

Dr. Preston Linn, Industry Academic Coordinator, NC State University. adjwqk@r.postjobfree.com; (919) 551- 5252

PERFORMANCE SKILLS DEMONSTRATED - As President and Chief Executive Officer North Carolina Biotechnology Center

Planning and Organizing

Provided overall leadership, supervision, direction and oversight to the development and maintenance of the program project plan(s) of the Center. The plan includes:

a. Corporate

1. Mission, Goals and Vision Statements

2. Organizational Plan

3. Finance Plan

b. Divisional

1. Objectives for each Program

2. Schedule of activities and resources needed to achieve the objectives of the Corporate Plan

3. A Staffing Plan, with organization structure and management teams

4. Yearly Work Plan strategies to accomplish the objectives

Responsible for the planning, design and fundraising ($6.0m) for the new headquarters building; Construction completed 1992.

Appointed by Governor Hunt to serve as member of the Governor's Task Force for the Supercomputer Project.

Served as a participant for the Governor's Far East Mission - fourteenth annual Southeast U.S.-Japan Association Meeting and the U.S.-Korea Economic Council meeting in Seoul, 1991-1993; Governor’s Israeli Trade Mission, 1995; Governor’s European Trade Mission, 1997and 2000.

Knowledge and Understanding

Carried out program activities which include but are not limited to the following: provided coordination and stimuli for research in biotechnology in appropriate academic institutions and businesses in North Carolina; assisted agencies of the North Carolina State government to establish and maintain effective working relations with academics, industry and other such components of state activity; planed, developed, constructed, maintained and otherwise operated appropriate facilities in furtherance of the charitable, educational and scientific purposes of the corporation; and improved the understanding of biotechnology among all sectors of North Carolina society.

Served as Chairman of the Advisory Committee on Biotechnology in Agriculture and the Genetic Engineering Review Board, 1990-1995. Served also on the Governor Martin’s Marine Sciences Policy Task Force, 1989. Served on the Executive Committee of the Biotechnology Development and Transfer Advisory Committee, 1994.

Initiated and developed a biotechnology initiative for the six Historically Minority Universities (1993 to 2002) utilizing a $10.0M appropriations to equip laboratories and develop a five year plan to hire faculty in life sciences and train several hundred students for graduate school, graduate health sciences or workforce. Received an Honorary Doctoral Degree from Elizabeth City State University. Initiated establishment of two biotech training sites: BRITE for laboratory and clinical technicians at NCCU and BTEC for manufacturing technicians at NCSU.

Economic Business and Finance Understanding

Fostered and promoted joint research and economic development programs with universities, industry and governmental agencies such as NSF, NIH, and NC Departments of Agriculture and Commerce and divisions such as the Extension Service and Center for Rural Economic Development for SBIR, STTR and TRP programs.

Directed the development of an economic development program that included technology transfer and development with an advisory committee; A successful investment program ( convertible loan fund ) to seed fund start-up biotechnology companies ($12m invested, 63 start-ups in twelve years with follow on funding of $475m from venture capital) with innovative investment approaches to protect the cash flow of the emerging companies, and a business services group that provided information and advice to young companies.

Conceived and established the North Carolina Bioscience Investment Fund. A $26m seed fund for small life science companies.

Participated in recruitment of a number of corporations such as BASF, Novo Nordisk, Covance, Biogen, Bayer, etc.

Member of Economic Strategy Committee of Triangle J Council of Governments, Council for Entrepreneurial Development, Center for Aseptic Process and Packaging Studies and Governor’s Council of Alliance for Competitive Technology (NCACTS.)

Communication

Developed a concise, informative format for reporting project status to the Executive Committee and Board of Directors. Also developed special reports and undertook special assignments as requested by the Board of Directors.

Developed liaison approaches to interact with the State General Assembly and reports for Joint Legislative Commission on Governmental Operations.

Developed a program management/team based method of operations for the Center.

Member of the Board of Directors-NC Association for Biomedical Research, 1993-1996.

PUBLICATIONS ( since 1990)

Editor: Drug Development 2nd Edition. CRC Press, Inc., 1990, Boca Raton, Florida.

Papers

Hamner, C.E., Laundon, T.K. and Teater, B., North Carolina Poised to Profit from Biotech Boom. Business Leader, 8:22, 1996.

Hamner, C.E. and Teater, B., Biotechnology: A New Wave for North Carolina. Carolina Banker, Winter, 1998, p. 10.

Book Reviews

Dibner, M.D. and Hamner, C.E. U.S. State Biotechnology Center - Analyzing the Trends for the 1990's. Genetic Eng. News 10, No. 8:8, 1990.

Dibner, M.D. and Hamner, C.E. Successful Biotechnology Centers Fashion Strategies to Include Key Support Groups. Genetic Eng. News 12, No. 2:4, 1992.

Hamner, C.E., Biotechnology Development and Education. ASM News 60, No. 4:170, 1994

Ono, R. Dana ed.,The Business of Biotechnology: From the Bench to the Street. Butterworth-Heinemann, 1991, 369 pages. American Scientist,v.80(6) Nov.-Dec. 1992.

Book Forward

Sibley, Kenneth D., The Law and Strategy of Biotechnology Patents. Butterworth-Heinemann, Newton, MA, 1994, 264 pages.

Leadership, Innovation, Development of Subordinates

Exercised general charge and supervision of the affairs of the corporation (including authority to hire and dismiss employees and to determine the compensation of employees other than officers) and performed such other duties and had such powers as may be assigned by the Board of Directors.

A member of the Board of Directors and of the Executive Committee of the Board. Reported to the Chairman of the Board of Directors.

Established policies and oversaw development of procedures for administration, personnel, purchasing, finance and other NCBC operations and assigned areas of responsibility to division heads and special program directors.

Established a Business and Technology Development Division to include staffing, development of programs for grants and loans, standard operating procedures, and technology transfer.

Appointed by the Governor to serve on the North Carolina Board of Science and Technology, 1991 until 2002.

Received the Council for Entrepreneurial Development’s 1995 Award for Outstanding Service to Entrepreneurs.

Elected to Strathmore’s Who’s Who Registry of Business Leaders, 1996.

Elected President, Research Triangle Owners and Tenants Association, 1996-1998. Represents 94 corporations and service organizations.

Elected member of the Triangle Area Salvation Army Advisory Board, 1996.

Invited Lectures in Biomedical Community:

Deliver 30 to 50 miscellaneous speeches per year on biotechnology’s impact on education, business and society. Examples:

Microelectronics Center of North Carolina - SBIR - A tool to support Scientific - Based Business Development, 1989. Biotechnology Center support for Entrepreneurial Business. Research Triangle Park, NC.

North Carolina Agribusiness Council, Inc., 1990. Biotechnology in Agriculture, Raleigh, NC.

Triangle J Council of Governments, 1990. Biotechnology and Its Impact in North Carolina. Research Triangle Park, NC.

NC Department of Commerce, 1991. Congressional Staff Briefing. Biotechnology in the U.S. and N.C. Raleigh, NC.

Committee on Science, Space and Technology, U.S. House of Representatives, Hearing before the Subcommittee on Technology and Competitiveness - Testimony on Biotechnology and Technology Transfer, May 6, 1991:102 Congress No. 27, p.29.

U.N.C. at Charlotte, 1991. North Carolina Biotechnology Center Programs for Building University/Industrial Relations and Economic Development, Charlotte, NC.

BASF, 1991. Briefing for the Science Diplomats Club of Washington, N.C. Biotechnology Center programs in Technology Development. Research Triangle Park, NC.

N.C. Biotechnology Center, 1992. Briefing for N.C. Press Association. Biotechnology: From the Lab to the Market Place. Research Triangle Park, NC.

Duke University, 1992. A Public forum on America's Medical Research. Biomedical Research and the Role of Biotechnology. Durham, N.C.

Sed Corp, Solono County, CA, 1992. Economic Development Forum on Biotechnology; Biotechnology Development in North Carolina, Fairfield, CA.

Congressional Testimony - Committee on Science, Space and Technology. Subcommittee on Technology, Environment and Aviation, 1992. Issues in Biotechnology Competitiveness, Research Triangle Park, NC.

American Association of Veterinary Medical Colleges, 1993. Armistead Lecture; Strategic Planning for Results. AVMA Annual Meeting, Minneapolis, MN.

Biotechnology Summit, 1994. Education: Simple Conclusions, Hard Work. Washington DC.

Venture ’95 - Duke University/CED, 1995. Keys to Successful State Technology Development Programs. Durham, NC.

Industrial Society for Pharmaceutical Engineers (ISPE), 1995. Emerging Issues and Opportunities in the Biopharmaceutical Industry and How the North Carolina Biotechnology Center Approaches Those Issues. Raleigh, NC.

University of Ulster, 1996. Biotechnology, the Global Scene and the North Carolina Experience. Coleraine, Ireland.

Association for Corporate Growth, 1997. Developing a New Technology, Raleigh, NC.

Workplace Perspectives: Research Integrity Form “Workplace” to the “Marketplace”, UNC - Chapel Hill, 1998.

Preparing For Business in the Biotechnology Revolution, Georgia Economic Developers Association, Atlanta, Georgia, August 17, 1998.

Leadership in the Management of Technology Development, Leaders in Action Program, Virginia Tech, Blacksburg, Virginia, December 3, 1998.

1999 to present: 3 to 4 presentations/year nationwide to academic, legislative and financial groups.

ACCOMPLISHMENTS IN PHARMACEUTICAL INDUSTRY

PERFORMANCE SKILL DEMONSTRATED:

Planning and Organizing

Director of Program Coordination in Research and Development. Established Program Coordination and Project Management System. This included development of project teams, precedent activity networks and time estimates to determine the critical developmental pathway for 24 NDA projects and 110 ANDA and reformulation projects.

Knowledge and Understanding

The IND/NDA projects involved the following therapeutic areas: Antiarrhythmic, Anti-inflammatory, Antihypertensive, Hypoglycemic, Antianxiety, Anti-schizophrenic, Anti prostaglandin, G.I. Motility Regulators, Contraceptives, Animal Growth Promoters, Parasite control, Long-acting Neuroleptic and Novel Drug Delivery Systems.

Specific Products I Developed and Marketed

Reglan (metoclopramide), Micro-K Extencaps (potassium chloride), Mitrolan (calcium polycarbophil), Biocox (salinomycin), Heparin (enzymatic derived), vitamin and cough - cold products (Robitussin; Dimmatap). OTC- lipquincer.

Economic and Business Understanding

Established program budgeting and project cost analysis. This included initial long-term cost estimates with a computerized effort reporting system to give an accumulated project cost analysis for comparison with original estimates of time and cost. Worked as a team member to build 2 manufacturing plants for liquid and solid dosage forms

Communications

Developed a concise, informative format for reporting project status to top management’s Pharmaceutical Development Committee.

Reviewed manufacturing procedures and wrote position paper to top management making recommendations for procedures to establish the Good Manufacturing Practices (GMP) Program to meet federal requirements.

Developed coordinated system for preparing medical monographs.

Editor: Drug Development. CRC Press, Inc., 1982, Boca Raton, Florida.

Editor: Drug Development, 2nd Edition. CRC Press, Inc., 1990, Boca Raton, Florida.

Leadership, Innovation, Development of Subordinates

Developed and coordinated program, as Chairman of Pharmacokinetics, for new compounds. This included biopharmaceutics, drug metabolism, bioavailability, pharmacokinetics, toxicology and clinical pharmacology. Also, established similar system for clinical developmental projects through the Drug Development Committee for Phase I, II, III and IV studies and interfaced with the Pharmaceutical Division for transfer of manufacturing specifications and preparation for marketing.

Reorganized and staffed a Toxicology Department and organized and staffed a Good Laboratory Practices Unit. This included the development of Standard Operating Procedures (SOP) for the entire Research and Development Division and establishment of a reports management distribution, storage, and retrieval system (Research and Development Archival Control Center).

Owner with Sharon B. Hamner of Hamner Research Services since 1978 to 2002 (Incorporated in 2002 as Hamner Advisory Services). This consulting service provides general management consulting to the pharmaceutical and biotechnology industry, scientific reviews of product proposals and grant applications (NIH, NSF, FDA, various foundations), literature reviews for product ideas and legal record searches. Experts are subcontracted to fill any special needs of a given project for financial, personnel or scientific (high-technology) input.

(Continued)

APPENDIX

INDUSTRY CONSULTATIONS

A. Ortho Pharmaceutical corporation, 1963.

Demonstrated installation of oviduct fluid collecting flasks.

B. Merck Sharpe and Dohme Research Laboratories, 1965.

Helped write reproduction section Merck Veterinary Manual, 3rd edition.

C. Wm. S. Merrell Company, 1966.

Lectured and advised on artificial insemination program for rabbits.

D. Schering, A.G., 1970.

Advised on contraceptive research and development.

E. Wm. Cooper and Nephews, Inc., 1972-1973

Advised and tested drugs for teratology effects in cats.

F. Hoffmann-LaRoche, Inc.

Advised on contraceptive research and development.

G. A.H. Robins Company, 1971-1978

Consultant in reproductive physiology, 1971-1973.

Consultant in all aspects of management of R&D.

Pharmaceutical Drug Development, 1974-1978.

H. Medical Development systems, Inc., 1983-1986.

Advised on automation of clinical studies data.

I. Venture First Associates, 1982-1988.

Advised on biotechnology research and development.

NATIONAL INSTITUTES OF HEALTH

A. Child Health and Human Development Program Project Committee, 1969 Site Visitor.

B. Reproduction and Perinatal Biology Training Review Committee, 1969 Site Visitor.

C. Environmental Health Training Committee, Site Visitor, 1979 Conducted workshop in 1974 at NIEHS in Research Triangle, North Carolina.

D. Center for Population Research - Rockefeller Foundation, Review Panel for Contracts on Oviduct and Uterus, 1973-1974.

E. Animal Resources Review Committee, 1982-1986; Chairman, 1986.

VIRGINIA HEART ASSOCIATION

Research Committee, 1968-1972

NATIONAL SCIENCE FOUNDATION

Developmental Biology Program, 1973, Consultant

FORD FOUNDATION

Member of Panel on Status of Research on Oviductal Function, 1973-1975

WORLD HEALTH ORGANIZATION

Task Force on Methods for the Regulation of Ovum Transport: Section on Human Oviduct Physiology and Biochemistry. Member of Panel and Program Participant, 1973-1976.

ASSOCIATION OF ACADEMIC HEALTH CENTERS

Member of Fiscal/Administrative Officers, 1980-

Member of the Planning Committee of Fiscal Officer's Group, 1981-1987

Chairman of the Planning Committee of Fiscal Officer's Group, 1984-1985

INVITED LECTURES AND VISITING PROFESSORSHIPS

University of North Carolina, 1965 - Ob. & Gyn. Seminar - Oviductal Fluid.

University of Michigan, 1966 - Ob. & Gyn. Seminar - Biochemistry of Oviductal Fluid - Demonstration - Oviduct Fluid Collecting Flask.

Washington State University, 1967 - Symposium - The Mammalian Oviduct; Lecture - Biochemistry of Oviductal Secretions; Film - Installation of Oviduct Fluid Collecting Flask; Demonstration - Installation of Oviduct Fluid Collection Flask.

Institute Mexicana de Seguro Social -

1967 - Course in Reproductive Physiology

1968 - Laboratory Techniques in Reproductive Physiology

Wayne State University, 1969 - Symposium - Pathways to Conception; Lecture - The Oviductal Fluid.

Cambridge University, England, 1970 - Lecture - Some Aspects of Reproductive Physiology in the Male and Female Cat.

Schering Symposium - Venice, Italy, 1970 - Symposium - Intrinsic and Extrinsic Factors in Early Mammalian Development; Lecture - Composition of Oviductal and Uterine Secretions.

National Institutes of Health, Bethesda, Maryland, 1970 - Conference - The Regulation of Mammalian Reproduction; Lecture - Physiology of Sperm in the Female Reproductive Tract.

University of Georgia College of Veterinary Medicine, 1971 - Physiology Lecture - Function of the Mammalian Oviduct.

Thomas Jefferson University, School of Medicine, Philadelphia, 1974 - Lecture - Embryo Culture in Oviductal Fluid.

University of Pennsylvania School of Medicine, 1974 - Lecture - Recent Advances in our Knowledge of Oviductal Fluid.

The Medical Center, Department of Obstetrics and Gynecology, Columbus, Georgia, 1975 - Lecture - Development of Vaginal Contraceptives.

University of Tennessee, Department of Biology, 1977 - Lecture - Oviductal Physiology and Function.

Pharmaceutical Manufacturers Association, Boston, Massachusetts, April, 1985 - Keynote Address - Drug Development: An Overview of Activities and Management.

Drug Information Association, Atlanta, Georgia, June, 1985 - Speech - Management's Role in Facilitating Drug Development.

Duke University, 1988 - Engineering Research Center. The Biotechnology Center's Institutional Development Program, Durham, NC.

North Carolina State University, 1989. 4th International Conference of the Pulp and Paper Industry. An overview of Biotechnology, Raleigh, NC.

N.C. Economic Development Council, 1989. The Biotechnology Center's Economic Development program. Pinehurst, NC.

PUBLICATIONS

Thesis

Hamner, C.E., Jr. Studies on the metabolism of spermatozoa. M.S. Thesis, University of Georgia, Athens, 1962.

Hamner, C.E., Jr. Effect of the female reproductive tract on spermatozoa. Ph.D. Thesis, University of Georgia, Athens, 1964.

Abstracts

Hamner, C.E., Jr. and Williams, W.L. Effect of the female tract on sperm respiration. Fed. Proc. 21: 436, 1962.

Williams, W.L. and Hamner, C.E. Effect of light on sperm metabolism. Fed. Proc. 21: 437, 1962.

Williams, W.L. and Hamner, C.E. Stimulation of respiration of spermatozoa. Fed. Proc. 22: 473, 1963.

Hamner, C.E. and Williams, W.L. Effect of the female reproductive tract on sperm metabolism. J.A.V.M.A. 142: 1241, 1963.

Hamner, C.E. and Williams, W.L. Effect of bicarbonate on the respiration of spermatozoa. Fed. Proc. 23: 430, 1964, and Ga. Academy of Sci. 22: 14, 1964.

Hamner, C.E. Effect of the female reproductive tract on spermatozoa. Dist. Abst. 6504491, 1965.

Hamner C.E. Studies of capacitation on spermatozoa. The Va. J. of Sci. 17: 342, 1966.

Hamner, C.E. Physiological considerations in capacitation of spermatozoa. Va. Academy Sci., 1968.

Sojka, N.J. (introduced by Hamner, C.E.) Artificial insemination in the cat. Va. Academy Sci., 1969.

Hamner, C.E., Jennings, L.L., and Sojka, N.J. In vitro fertilization of cat (Felis catus L.) eggs. Va. J. Sci. 22: 132, 1971.

Kille, J. W. and Hamner, C.E. The effect of oviduct fluid on the development of fertilized rabbit ova in vitro. Biol. Reprod. 5: 102, 1971.

Lambert, J.C. and Hamner, C.E. Ultrastructure of the rabbit oviduct. Va. J. Sci. 23: 144, 1972.

McLaughlin, K.C. and Hamner, C.E. The presence of decapacitation factor in cat seminal plasma. Va. J. Sci. 23: 144, 1972.

Hamner, C.E., McLaughlin, K.C., and Sojka, N.J. Some observations on semen and fertilization in the cat. Amer. Assoc. Lab An. Sci., abst. 72-3, #99, 1972.

Lambert, J.C., Hamner, C.E. and Gemmill, C.L. An ultrastructural study of secretion in the rabbit oviduct under different hormonal influences. Fed. Proc. 32(3) 213, 1973.

Papers

Hamner, C.E., Jr. Nutrition of the cat. Southeastern Vet. 11(1) 8, 1960.

Hamner, C.E., Jr. and Williams, W.L. The effects of light on the respiration of spermatozoa. Biochem. Biophys. Res. Comm. 5: 316, 1961.

Hamner, C.E. and Williams, W.L. Effect of the female reproductive tract on sperm metabolism in the rabbit and fowl. J. Reprod. Fert. 5: 143, 1963.

Williams, W.L. and Hamner, C.E. The stimulation of respiration of spermatozoa by light and certain chemicals. J. Reprod. Fert. 6: 235, 1963.

Williams, W.L., Weinman, D.E., and Hamner, C.E. Effect of the female reproductive tract on spermatozoa. Proc. 5th Internat. Congress Art. Incem. 111/2: 367, 1964.

Hamner, C.E. and Williams, W.L. The composition of rabbit oviduct secretions. Fertil. Steril. 16: 170, 1965.

Hamner, C.E. and Sojka, N.J. Capacitation of rabbit spermatozoa: species specificity and organ specificity. Proc. Soc. Exp. Biol. Med. 124: 689, 1967.

Hamner, C.E., Jones, J.P., and Sojka, N.J. Influence of the hormonal state of the female on the capacitation of rabbit spermatozoa. Fertil. Steril. 19: 137, 1968.

Hamner, C.E. and Fox, S.B. Effect of estrogen and progesterone on the physical properties of rabbit oviduct fluid. J. Reprod. Fert. 16: 121, 1968.

Hamner, C.E., Jones, J.P. and Fox, S.B. Effect of estrogen and progesterone on the respiration and glysolysis of the rabbit oviduct. Fertil. Steril. 20: 143, 1969.

Sojka, N.J., Jennings, L.L. and Hamner, C.E. Artificial insemination in the cat (Felis Catus L.). Lab. An. Care. 20: 198, 1970.

Hamner, C.E., Jennings, L.L. and Sojka, N.J. Cat (Felis Catus L.) spermatozoa require capacitation. J. Reprod. Fert. 23: 477, 1970.

Brown, S.M. and Hamner, C.E. Capacitation of sperm in the female reproductive tract of the rabbit during estrus and pseudopregnancy. Fertil. Sterl. 22: 92, 1971.

Hamner, C.E. and Wilson, L.A., Jr. Inhibition of capacitation in the rabbit. Fertil. Steril. 23: 196, 1972.

Simmons, J.G. and Hamner, C.E. Inhibition of estrus in the dog with testosterone implants. Am. J. vet. Res. 34: 1409, 1973.

Kille, J.W. and Hamner, C.E. The influence of oviductal fluid on the development of one-celled rabbit embryos in vitro. J. Reprod. Fert. 35: 415, 1973.

McLaughlin, K.C. and Hamner, C.E. A demonstration of cat seminal fluid plasma antifertility activity. Proc. Soc. Exp. Biol. Med. 145: 103, 1974.

Serano, R.D., Jones, J.P., Wilson, L.A. and Hamner, C.E. Capacitation in the rabbit: Stimulation, inhibition, and recovery from inhibition. Proc. Soc. Exp. Biol. Med. 145: 983, 1974.

McLaughlin,

Contact this candidate